07.12.11
Cook Medical Inc. has received premarket approval from the U.S. Food and Drug Administration for the Zenith Spiral-Z AAA Iliac leg graft, for patients with abdominal aortic aneurysms requiring graft support in the iliac artery.
“Zenith Spiral-Z provides physicians with Cook’s most kink-resistant and trackable iliac leg graft to date,” said Phil Nowell, vice president of Cook Medical's Aortic Intervention division.
Zenith Spiral-Z offers enhanced flexibility and kink resistance due to a continuous nitinol spiral stent, as well as increased radial force at the proximal sealing site. It also features the Z-Trak Introduction System, which features polytetrafluoroethylene-coated lumen for reduction of surface friction and precise device delivery.
Zenith Spiral-Z was launched in Europe following CE Mark approval in April 2011, as part of Cook Medical’s Zenith Flex AAA Endovascular Graft product line.
Cook Medical is based in Bloomington, Ind.
“Zenith Spiral-Z provides physicians with Cook’s most kink-resistant and trackable iliac leg graft to date,” said Phil Nowell, vice president of Cook Medical's Aortic Intervention division.
Zenith Spiral-Z offers enhanced flexibility and kink resistance due to a continuous nitinol spiral stent, as well as increased radial force at the proximal sealing site. It also features the Z-Trak Introduction System, which features polytetrafluoroethylene-coated lumen for reduction of surface friction and precise device delivery.
Zenith Spiral-Z was launched in Europe following CE Mark approval in April 2011, as part of Cook Medical’s Zenith Flex AAA Endovascular Graft product line.
Cook Medical is based in Bloomington, Ind.